Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Oyster Point Pharma, Inc. | d861497dex51.htm |
| S-1MEF - S-1MEF - Oyster Point Pharma, Inc. | d861497ds1mef.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated February 27, 2020 relating to the financial statements, which appears in the Registration Statement on Form S-1 (No. 333-238194) of Oyster Point Pharma, Inc. We also consent to the reference to us under the heading “Experts” in the Registration Statement on Form S-1 (No. 333-238194) incorporated by reference in this Registration Statement.
/s/ PricewaterhouseCoopers LLP
Florham Park, NJ
May 14, 2020